Steven Harrison

Steven Harrison


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2018 in Human Mutation
Verified
Journal Article
Closed access
PDF file
ATAhmad N. Abou Tayoun
Ahmad N. Abou Tayoun
TPTina Pesaran
Tina Pesaran
MDMarina T. DiStefano
Marina T. DiStefano
AOAndrea Oza
Andrea Oza
HHeidi Rehm
Heidi Rehm
CSClinGen Sequence Variant Interpretation Working Group (ClinGen SVI)
ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI)

22 June 2023 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
LWLogan Walker
Logan Walker
MHMiguel de la Hoya
Miguel de la Hoya
GWGeorge A.R. Wiggins
George A.R. Wiggins
ALAmanda Lindy
Amanda Lindy
LVLisa M. Vincent
Lisa M. Vincent
STScott Topper
Scott Topper

1 March 2018 in Genetics in Medicine
Verified
Journal Article
Open access
MKMelissa A. Kelly
Melissa A. Kelly
CCColleen Caleshu
Colleen Caleshu
AMAna Morales
Ana Morales
JBJillian Buchan
Jillian Buchan
ZWZena Wolf
Zena Wolf
BFBirgit Funke
Birgit Funke
Integrating genomic sequencing in clinical care requires standardization of variant interpretation practices. The Clinical Genome Resource has established expert panels to adapt the American College of Medical Genetics and Genomics/Association for Molecular Pathology classification framework for specific genes and diseases. The Cardiomyopathy Expert Panel selected MYH7, a key contributor to inherited cardiomyopathies, as a pilot gene to develop a broadly applicable approach. Expert revisions were tested with 60 variants using a structured double review by pairs of clinical and diagnostic laboratory experts. Final consensus rules were established via iterative discussions. Adjustments represented disease-/gene-informed specifications (12) or strength adjustments of existing rules (5). Nine rules were deemed not applicable. Key specifications included quantitative frameworks for minor allele frequency thresholds, the use of segregation data, and a semiquantitative approach to counting multiple independent variant occurrences where fully controlled case-control studies are lacking. Initial inter-expert classification concordance was 93%. Internal data from participating diagnostic laboratories changed the classification of 20% of the variants (n = 12), highlighting the critical importance of data sharing. These adapted rules provide increased specificity for use in MYH7-associated disorders in combination with expert review and clinical judgment and serve as a stepping stone for genes and disorders with similar genetic and clinical characteristics.

15 March 2018 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
LBLeslie G. Biesecker
Leslie G. Biesecker
SHSteven Harrison
Steven Harrison

8 August 2019 in Current Protocols in Human Genetics
Verified
Journal Article
Open access
PDF file
SHSteven Harrison
Steven Harrison
LBLeslie G. Biesecker
Leslie G. Biesecker
HRHeidi L. Rehm
Heidi L. Rehm
The 2015 ACMG/AMP guidelines established a classification system for sequence variants; however, the broad scope of these guidelines necessitates specification of evidence types for specific genes or diseases of interest. Since publication of the guidelines, both general use and disease‐focused specifications have emerged to aid in accurate application of ACMG/AMP evidence types. This article summarizes the approaches to, and rationale for, specifying three evidence categories (population frequency data, variant type and location, and case‐level data), including available resources and a quantitative framework that can inform the specification process. © 2019 by John Wiley & Sons, Inc.

16 March 2017 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
SHSteven Harrison
Steven Harrison
JDJill S. Dolinsky
Jill S. Dolinsky
AJAmy E. Knight Johnson
Amy E. Knight Johnson
TPTina Pesaran
Tina Pesaran
DADanielle R. Azzariti
Danielle R. Azzariti
HHeidi Rehm
Heidi Rehm
Purpose: Data sharing through ClinVar offers a unique opportunity to identify interpretation differences between laboratories. As part of a ClinGen initiative, four clinical laboratories (Ambry, GeneDx, Partners Healthcare Laboratory for Molecular Medicine, and University of Chicago Genetic Services Laboratory) collaborated to identify the basis of interpretation differences and to investigate if data sharing and reassessment resolve interpretation differences by analyzing a subset of variants. Methods: ClinVar variants with submissions from at least two of the four participating laboratories were compared. For a subset of identified differences, laboratories documented the basis for discordance, shared internal data, independently reassessed with the American College of Medical Genetics and Genomics–Association for Molecular Pathology (ACMG-AMP) guidelines, and then compared interpretations. Results: At least two of the participating laboratories interpreted 6,169 variants in ClinVar, of which 88.3% were initially concordant. Laboratories reassessed 242/724 initially discordant variants, of which 87.2% (211) were resolved by reassessment with current criteria and/or internal data sharing; 12.8% (31) of reassessed variants remained discordant owing to differences in the application of the ACMG-AMP guidelines. Conclusion: Participating laboratories increased their overall concordance from 88.3 to 91.7%, indicating that sharing variant interpretations in ClinVar—thereby allowing identification of differences and motivation to resolve those differences—is critical to moving toward more consistent variant interpretations. Genet Med advance online publication 09 March 2017